These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35802867)

  • 1. Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
    Chun S; Choi CB; Kim MS; Nam JY; Lee TY; Lee YT; Kim S; Han SB; Bae SC
    Lupus; 2022 Sep; 31(10):1245-1253. PubMed ID: 35802867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
    Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
    Front Immunol; 2021; 12():662441. PubMed ID: 34248942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.
    Yang X; Yang J; Li X; Ma W; Zou H
    Lupus; 2018 Jan; 27(1):49-59. PubMed ID: 28537524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
    Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
    Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
    Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
    Front Immunol; 2020; 11():233. PubMed ID: 32133007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
    Uccelli A; Laroni A; Ali R; Battaglia MA; Blinkenberg M; Brundin L; Clanet M; Fernandez O; Marriot J; Muraro P; Nabavi SM; Oliveri RS; Radue E; Ramo Tello C; Schiavetti I; Sellner J; Sorensen PS; Sormani MP; Wuerfel JT; Freedman MS;
    Lancet Neurol; 2021 Nov; 20(11):917-929. PubMed ID: 34687636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential efficacy of human mesenchymal stem cells based on source of origin.
    Collins E; Gu F; Qi M; Molano I; Ruiz P; Sun L; Gilkeson GS
    J Immunol; 2014 Nov; 193(9):4381-90. PubMed ID: 25274529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
    Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
    Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
    Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
    Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial.
    Ranjbar A; Hassanzadeh H; Jahandoust F; Miri R; Bidkhori HR; Monzavi SM; Sanjar-Moussavi N; Matin MM; Shariati-Sarabi Z
    Curr Res Transl Med; 2022 May; 70(2):103324. PubMed ID: 34979487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.
    Xu L; Dai Q; Zhang Y; Lin N; Ji L; Song X
    Cell Transplant; 2024; 33():9636897241236586. PubMed ID: 38469823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
    Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
    Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
    Liu S; Guo YL; Yang JY; Wang W; Xu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients.
    Carrion F; Nova E; Ruiz C; Diaz F; Inostroza C; Rojo D; Mönckeberg G; Figueroa FE
    Lupus; 2010 Mar; 19(3):317-22. PubMed ID: 19919974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus.
    Cao Z; Wang D; Jing L; Wen X; Xia N; Ma W; Zhang X; Jin Z; Shen W; Yao G; Chen W; Tang X; Geng L; Li H; Li X; Ding S; Liang J; Feng X; Zhang H; Liu S; Li W; Sun L
    Stem Cells Transl Med; 2023 Jul; 12(7):431-443. PubMed ID: 37279956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
    Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
    Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.